We get a lot of expertise and positive energy from their support
Cherry Biotech works hand in hand with two labs of the Institute of Genetics and Development, Rennes, a major life sciences research center.
Cherry Biotech is also happy to constantly develop new applications in close relation with relevant top-field teams such as Julien Dumont’s team from the Institut Jacques Monod, Paris.
Dr Damien Coudreuse
Damien graduated from ENS Cachan in Paris and performed his thesis research at the Hubrecht Institute, Utrecht, Netherlands. He did his post-doc in Sir Paul Nurse’s lab at Rockefeller University, NY,USA before starting his CNRS SyntheCell team in Rennes. Damien is the recipient of an ERC grant from the European Union.
The SyntheCell team uses synthetic biology to get a better and more detailed understanding on the basic principles underlying fundamental cellular processes. They implement in vivo functional model circuits to understand the basis of natural cellular networks using the fission yeast cell cycle as a model.
Dr Pei-Yun Jenny Wu
Genome Duplication & Maintenance
Pei-Yun Jenny Wu got her PhD from the Harvard University and did her post-doc at the Rockefeller University, NYC, NY, USA. She holds a permanent position at CNRS and is funded by a french grant “Fondation pour la Recherche Medicale, ATIP-Avenir program of the CNRS-INSERM” as well as international organizations (Association for International Cancer Research UK, EU-FP7).
She is at the head of the Genome Duplication and Maintenance team: their work uses the fission yeast Schizosaccharomyces pombe as a model to investigate the mechanisms regulating origin selection and genome fidelity.
Dr Julien Dumont
Division cellulaire et reproduction
Julien Dumont did his Ph.D. in Paris before moving to UCSD (San Diego, USA) where he started to work with the powerful soil worm Caenorhabditis elegans. During his post-doc in Arshad Desai’s lab, he used the worm to discover an original mechanism of chromosome segregation. After a short second post-doc at Institut Curie in Paris during which he learned the basics of microfluidics and its application to temperature control, Julien Dumont started his own independent CNRS research team at Institut Jacques Monod in 2012. Although people in Julien Dumont’s team use different model systems that range from tissue culture cells to mice, their favorite one to study cell division is still C. elegans. That’s why they were our obvious partners when we needed help to adapt CherryTemp to C. elegans research. Check out Julien Dumont’s team webpage @IJM and their publications that refer to CherryTemp:
Davies, T., Sundaramoorthy, S., Jordan, S.N., Shirasu-Hiza, M., Dumont, J., and Canman, J.C.
Using fast-acting temperature sensitive mutants to study cell division in C. elegans.
Methods Cell Biol. 2017;137:283-306 Abstract
Gigant, E.*, Stefanutti, M.*, Laband, K., Gluszek-Kustusz, A., Edwards, F., Maton, G., Lacroix, B., Canman, J.C., Welburn, J. & Dumont, J.
Inhibition of ectopic microtubule assembly by the kinesin-13 KLP-7MCAK prevents chromosome segregation and cytokinesis defects in oocytes
Development, (2017), in press Abstract
On the entrepreneurial side, we benefit from precious supports both from local and wider networks
BPI France – French Ministry of Education and Research
We are proud laureate of the Concours National d’aide à la Création d’Entreprises de Technologies Innovantes (National competition to support start-up companies creation in Innovative Technology) organized by the French Ministry of National Education, Higher Education and Research.
In 2014, the BPI supported us to commercialize our first product: a temperature controller which allows an unprecedent control of living cells. In June 2016, we have been supoprted for our ambitious “Human-on-a-chip” project. Our objective? Kind of “simple”: mimic human body organs on micro-devices to allow drug testing and patient diagnosis.
As an innovative life sciences start-up company, Cherry Biotech receives support from Emergys, a life sciences incubator in Britany, financed by the french ministry of research. Emergys is a member of the Rennes Atalante structure highly supported Cherry Biotech’s development. Rennes Atalante aims at developping the Rennes area’s economy by supporting the creation and development of innovative companies.
Biosit is a biology and health research federative structure. It is also an entity offering services through its 14 technological platforms. A triple mission is guiding Biosit’s policy: 1/ federate research teams – 2/ manage and develop technology platforms – 3/ build relationships between public and private biotechs. This third mission has a direct consequence on Cherry Biotech’s development.
Cherry Biotech is proud to be located on the Rennes I University. This is key to build strong relationship with academic labs.
Cherry Biotech receives a precious support from local partners. The Britanny council is one of these important actors which accelerates its development and shinning over the world.
Since the very beginning of our story, we have been supported by key actors of the Rennes area like ID2Santé. Their mission is to promote co-operation between research units and companies involved in R&D of health-related technologies in Bretagne (Western France), provide technological assistance and expertise, meet requests for partnerships and assist project leaders in R&D projects. ID2Santé field of expertise include medical devices, health technologies, nutrition, biotechnologies, drug development and new therapies.